Cheminformatics-based identification of phosphorylated RET tyrosine kinase inhibitors for human cancer
{{output}}
Background: Rearranged during transfection (RET), an oncogenic protein, is associated with various cancers, including non-small-cell lung cancer (NSCLC), papillary thyroid cancer (PTC), pancreatic cancer, medullary thyroid cancer... ...
